Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-20

FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lithobid (lithium carbonate) from ANI Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithobid (lithium carbonate)

Snippet

SUPPL AP for LITHOBID (LITHIUM CARBONATE)